To determine the influence of renal failure on the pharmacokinetics and neuromuscular blockade of Org NC 45 (Norcuron), a new monoquaternary homologue of pancuronium, 13 patients under halothane and nitrous oxide anaesthesia were studied. Org NC45 was administered by 2-min infusion in doses of 0.28mgkg" 1 (normal renal function group, n = 4) and 0.14mgkg"' (renal failure group, n = 5). Four additional patients with normal renal function were given Org NC45 0.14mgkg~' to determine the onset, duration and recovery rate of neuromuscular blockade. The serum concentration of Org NC 45 was determined by normal-phase high performance liquid chromatography (sensitivity 50ngml~'), and a two-compartment open pharmacokinetic model was fitted to resulting data. Estimates of distribution half-life (Tf), elimination half-life ( T/), volume of distribution at steady state (V ") and clearance of Org NC 45 did not differ significantly between patients with normal renal function and those with renal failure. The onset, duration and recovery rate times of the neuromuscular blockade by OrgNC450.14mg kg"' in patients with normal renal function and those with renal failure also did not differ significantly.
Org NC45 (Norcuron) is a monoquaternary homologue of pancuronium developed by Savage, Sleigh and Carlyle (1980) which produces a neuromuscular blockade of shorter duration than pancuronium and which apparently is devoid of any cardiovascular effects in both animals and man Marshall et al., 1980) . The shorter duration of action of Org NC 45 may be a result of its shorter elimination half-life. Van der Veen and Bencini (1980) found the elimination half-life of Org NC 45 to be less than that published for pancuronium (31 min v. 133 min) by Somogyi, Shanks and Triggs (1976, 1977) . However, in their Org NC45 study, the elimination half-life was determined from plasma concentration values apparently collected over 1 h following administration of Org NC45 compared with at least 6h for pancuronium. Durant, Houwertjes and Agoston (1979) found that duration of neuromuscular blockade following Org NC45 was not prolonged by ligation of renal pedicles in cats; the duration of pancuronium block was significantly prolonged. We have compared the pharmacokinetics and neuromuscular blockade of Org NC45 in patients with normal renal function with those with renal failure.
METHODS
Fifteen adult surgical patients (20-55 yr, 50-90 kg) gave signed consent for the study which had local approval of ethics. Eight of the patients had normal renal function and were undergoing elective surgery. In four of these the pharmacokinetics of Org NC 45 0.28 mg kg" 1 were studied; in the other four neuromuscular blockade by Org NC45 0.14mgkg~' was studied. Five patients had renal failure and were to receive cadaver kidney transplants. The pharmacokinetics and neuromuscular blockade of Org NC45 O.Hmgkg" 1 were studied. The blood urea and creatinine concentrations in the patients with renal failure were 76.3±23.4 (SD) mgdl" 1 and 12.4 + 2.6mgdl" 1 respectively. All patients with impaired renal function had undergone haemodialysis just before surgery.
After premedication with diazepam lOmg orally, anaesthesia was induced with thiopentone 1 mgkg" 1 i.v. and inhalation of halothane in 60% nitrous oxide in oxygen. The trachea was intubated without giving muscle relaxants. Ventilation of the lungs was controlled and anaesthesia maintained with 0.4-1.0% halothane end-tidal with 60% nitrous oxide, measured continuously with a mass spectrometer. Oesophageal temperature and were maintained within normal limits.
Neuromuscular function was evaluated by measuring the strength of thumb adduction with a force-displacement transducer (Grass FT-10) in response to supramaximal stimuli of 0.15 Hz and 0.2 ms duration (Grass S44 stimulator) delivered through two steel 27-gauge needles inserted subcutaneously over the ulnar nerve at the wrist. When the desired inhalation anaesthetic concentration had been maintained for at least 20 min, Org NC45 was infused continuously for 2 min, 0.28mgkg" 1 in patients with normal renal function (n = 4) and 0.14 mg kg "' in patients with renal failure (n = 5). Venous blood was sampled 4, 6, 8, 10, 15, 20, 25, 30, 45, 60, 75, 90, 105, 120, 150, 180, 210 , and 240 min after the start of the infusion. Samples for each were centrifuged and the serum combined with phosphate buifer 150 ulitre for each ml of serum to maintain stability of Org NC45. Samples were then frozen until analysis.
The analytical procedure was a modification of the method of Paanakker and Van de Laar (1980) , which uses normal-phase high performance liquid chromatography analysis. After the internal standard, neostigmine, was added, the serum samples were treated with saturated potassium iodide and Org NC 45 was extracted into dichloromethane as an ion pair. The dried residue from the organic layer was taken up in methanol 30 u litre and eluted through a Micropack Si-5 column with methanol containing 0.25% ammonia gas and tetramethylammonium chloride 8.5 mmol litre"
1 . Because of the basicity of the mobile phase, a precolumn hand-packed with LiChrosorb Si-60 was installed ahead of the injector. The sensitivity of the assay was 50 ng per ml of serum and the dayto-day precision ranged from 15% (coefficient of variation; n = 5) at 50 ng ml"' to 0.6% (coefficient of variation; n = 5) at 2.5ugml" 1 .
A two-compartment open pharmacokinetic model (equation (1)) was fitted to the serum concentration-time data weighting each point (1/concentration) (equation (2)).
( 1) where C P = Org NC 45 concentration in plasma; D = dose; t = time from commencement of dosing; T = duration of infusion; x = t while t<x, but T' = T when t > T; V = apparent volume of distribution in the sampled compartment; T, V, a, P and k 2 1 are estimated by least squares fit of the model to experimental C r , t data; V" estimated according to equation (2):
In the normal patient group, an elimination half-life was determined using the first 90 min of data to obtain an appropriate half-life to compare with that already published for Org NC 45 by Van der Veen and Bencini (1980) . Statistical comparisons of pharmacokinetic parameters were made by analysis of variance.
The following indices of neuromuscular blockade by Org NC45 O.Hmgkg" 1 were determined: the onset (time from injection to maximal twitch depression), the duration of action (time from injection to 90% recovery of control twitch), and the recovery rate (time for twitch to spontaneously recover from 25% to 75% of control twitch). These indices were obtained in four of the eight normal patients and four of the five renal failure group (the other renal failure patient required antagonism of neuromuscular blockade before adequate spontaneous recovery) and comparison was made again by analysis of variance. (table II) . There was no statistically significant difference in onset or recovery time between the two groups of patients.
RESULTS

Figure
DISCUSSION
The shorter duration of neuromuscular blockade of Org NC 45, when compared with pancuronium, may be at least partly explained by a shorter elimination half-life for Org NC45 (table I) . This elimination half-life of 79.5 ±13.6 min appears to be shorter than that found for pancuronium by Agoston and others (1973) but the pattern of elimination of the two drugs appears to be quite different. For example, in preliminary studies in rats, we found that 45% of an injected dose of Org NC45 was excreted unchanged in the bile in the 1st hour following administration, while less than 4% of unchanged pancuronium was excreted. Whether this preferential biliary excretion of Org NC 45 is also present in man remains to be determined. No significant difference was found between pharmacokinetic parameters for Org NC45 estimated for patients with normal renal function compared with those with renal failure. Certainly with a larger number of patients, a significant difference might have been demonstrated. Our data indicate that such a difference, if found, would be small in comparison with the difference in pancuronium clearance between patients with and without renal function, as found by Somogyi, Shanks and Triggs (1977) . Thus Org NC45 appears to be less dependent on renal excretion for its elimination than is pancuronium (table I) . A greater degree of hepatic elimination of Org NC 45 could explain these findings.
Patients in the renal failure group probably had an improvement in renal function at 116 ± 44 min after Org NC45 administration, as their transplanted kidney was perfused. Miller and others (1977) have shown that a newly transplanted kidney is capable of excreting tubocurarine. Obviously, we did not determine the extent to which Org NC 45 may have been excreted by the new kidney. Somogyi, Shanks and Triggs (1977) also studied patients receiving newly transplanted kidneys. The markedly prolonged elimination half-life of pancuronium in this study thus allows us to conclude that Org NC 45 is less dependent on renal excretion for its elimination than is pancuronium.
Because of the limited sensitivity of our assay, we were able to achieve a longer sampling time (4h) by administering a larger dose of Org NC45 (0.28mgkg" 1 ) to patients with normal renal function. In our renal failure group, however, we hesitated to use Org NC45 0.28 mg kg" 1 lest prolonged neuromuscular blockade occur. Thus half the dose was given (0.14 mg kg " ! ), which still allowed sampling time of 240 min. The influence of a longer sampling duration can be seen when comparing the "terminal" elimination half-life obtained using the first 90 min of serum concentration data (35 ±8 min) with that using all 240min (79.5 ± 13.6min). The study of Van der Veen and Bencini (1980) on the pharmacokinetics of Org NC45 suffers in this regard since their elimination half-life was 30.7+ 18.5 min. A more sensitive assay for Org NC 45 would give an even more accurate "terminal" elimination half-life than that estimated in this study.
Despite these large doses of Org NC45, the duration of neuromuscular blockade did not differ in patients with normal renal function and those with renal failure (table II) . This finding, combined with the similarity in pharmacokinetics, has led us to conclude that renal excretion may not be the main route of elimination of Org NC 45. Org NC45 may be a suitable non-depolarizing muscle relaxant for patients with impaired renal function. Se sometieron a cstudio 13 pacientes bajo anestesia efecruada por halotano y oxldo nitroso, para determinar la influencia del fallo renal en las farrhacocineticas y en el bloquco neuromuscular del Org NC45 (Norcuron), que es un homologo monocuaternario del pancuronio. El Org NC 45 se administro por infusion en dosis de 0,28 mg kg"' (grupo de funcion renal normal, n = A) y de 0,14mgkg"' (grupo de fallo renal, n = 5). A otros pacientes que presentaban una funcion renal normal se les administro Org NC45 0,14mgkg~' para determinar el inicio, la duradon y el regiinen de recuperacion del bloqueo neuromuscular. La concentracion de Org NC 45 en el suero se determin6 mediante cromatografia liquida de altas caracterisucas y fase normal (sensibilidad de 50ngml~'), y a la informaci6n resultante se le ajusto un modelo farmacocinetico de dos compartimentos. Las estimaciones de la vida media de la distribucion (7^"), la vida media de la eliminacidn (T±),i el volumen de distribucion en el estado de regimen (P^*) y la elimination del Org NC 45 no se diferencio de forma significative entre los pacientes con funciones renales normales y aquellos con fallo renal. Los tiempo correspondientes al inicio, duracion y regimen de recuperacion del bloqueo neuromuscular por pane del Org NC45 0,14mgkg"' en pacientes con funci6n renal normal y en los de fallo renal, no se diferenciaron de forma significative.
